TrialAmerican journal of clinical dermatology2026

Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.